Brinker Capital Investments, LLC Bausch Health Companies Inc. Transaction History

Brinker Capital Investments, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	BUY	$7.06 - $23.63 $7,462 - $24,976	1,057 Added 1.18%	90,974 $761,000
Q1 2022 May 16, 2022	SELL	$21.6 - $27.79 $208,893 - $268,757	-9,671 Reduced 9.71%	89,917 $2.06 Million
Q4 2021 Feb 08, 2022	SELL	$23.0 - $29.01 $88,803 - $112,007	-3,861 Reduced 3.73%	99,588 $2.75 Million
Q2 2021 Aug 03, 2021	BUY	$27.43 - $32.7 $141,072 - $168,176	5,143 Added 5.23%	103,449 $3.03 Million
Q1 2021 May 12, 2021	SELL	$21.37 - $34.38 $1.99 Million - $3.19 Million	-92,910 Reduced 48.59%	98,306 $3.12 Million
Q4 2020 Feb 16, 2021	BUY	$15.31 - $21.12 $1.6 Million - $2.21 Million	104,632 Added 120.84%	191,216 $3.98 Million
Q3 2020 Dec 03, 2020	BUY	$14.88 - $20.13 $1.29 Million - $1.74 Million	86,584 New	86,584 $1.35 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Brinker Capital Investments, LLC with notifications on news.